— All Articles —
The latest from The Peptide Brief.
GLP-1 muscle loss: what older UK patients need to know
A new study is warning that older adults on GLP-1 weight loss medicines may face hidden risks beyond the number…
Obesity medicines compared: why the biggest weight loss is not the whole story
A major new review of 262 clinical trials has ranked 19 obesity medicines by weight loss and cardiovascular benefit. The…
3.3 Million UK Adults Expected to Use Weight Loss Jabs in 2026 — What the Numbers Really Mean
NHS dispensing of weight loss injections passed 4 million items in a single year. An estimated 3.3 million UK adults…
Fake Wegovy Pills: How To Spot Counterfeit Weight Loss Medicine In The UK
Counterfeit Wegovy pills have appeared on unregulated websites almost immediately after the tablet form launched in UK pharmacies. Regulators and…
Wegovy Pill UK: Superdrug Becomes First Provider to Launch Oral Semaglutide After MHRA Approval
Superdrug has quietly made history by becoming the first UK provider to offer the Wegovy pill following MHRA approval, marking…
Jeremy Clarkson Weight Loss: What UK Patients Can Actually Learn From His Mounjaro Switch
Jeremy Clarkson has spoken publicly about trying Ozempic, experiencing difficult side effects, and later switching to Mounjaro. His journey has…
Are Retatrutide Warnings Helping Patients Or Causing Fear?
Media warnings about unlicensed retatrutide have divided patient communities, with some readers calling headlines alarmist and others welcoming stronger safety…
UK obesity medicine demand is outpacing NHS capacity, experts warn
Millions of Britons are now actively considering weight loss injections, but access, affordability and long-term support remain serious unresolved problems…
Millions Using Weight Loss Drugs But UK Access Remains a Postcode Lottery, Major Survey Finds
A landmark new survey reveals that millions of British adults have already tried weight loss drugs or are seriously considering…